期刊文献+

前列腺素E1对原位肝移植病人肺动脉高压的影响 被引量:3

THE EFFECT OF PGE1ON PULMONARY HYPERTENSION IN PATIENTS UNDERGOING ORTHOTOPIC LIVER TRANSPLANTATION
暂未订购
导出
摘要 目的探讨前列腺素E1(PGE1)对原位肝移植病人肺动脉高压的治疗作用,为临床用药提供理论指导。方法 2007年10月—2011年10月,选择原位肝移植病人15例,均有肺动脉高压。麻醉诱导后,从右颈内静脉放置漂浮导管,监测肺动脉压(PAP)及肺毛细血管楔压(PCWP)。经微量泵持续泵入PGE1 35μg·kg-1·min-1,分别观察无肝前期(T1)、无肝期(T2)、新肝期10min(T3)、新肝期30min(T4)、新肝期60min(T5)时PAP、PCWP、平均动脉压(MAP)及心率(HR)变化。结果 T2、T3、T4、T5与T1比较PAP明显降低,T3较T2的PAP明显升高,T4、T5与T3比较PAP明显降低,差异有统计学意义(F=32.78,P<0.05)。T2、T3、T4、T5与T1比较MAP明显降低,T3与T2比较MAP明显降低,T4、T5与T3比较MAP明显升高,差异有统计学意义(F=12.51,P<0.05)。T2、T3、T4与T1比较HR明显升高,T4、T5与T3、T2比较HR明显降低,差异有统计学意义(F=21.91,P<0.05)。结论经微量泵持续泵入PGE1 35μg·kg-1·min-1,对原位肝移植病人肺动脉高压有较好的治疗效果。 Objective To assess the therapeutic effects of prostaglandin E1 (PGE1) on pulmonary hypertension in pa- tients undergoing orthotopic liver transplantation (OLT). Methods Fifteen patients underwent OLT (2007.10-2011.10) were selected. All of them had pulmonary hypertension. After anesthesia induction, a Swan Ganz catheter was inserted from right inter hal jugular vein, and the pulmonary artery pressure (PAP) and pulmonary capillary wedge pressure (PCWP) were measured. PGE1 was injected at 35μg·kg^-1·min^-1 by a micro-pump. The changes of PAP, PCWP, mean arterial pressure (MAP) and heart rate (HR) were measured during preanhepatic (TI), anhepatic (T2), neohepatic 10 rain (T3), neohepatic 30 rain (T4) and neohepatic 60 rain (Ts). Results The PAP in T2, T3, T4 and T5 was greatly declined as compared with that in T1, and that in T3 was greatly elevated, and that in T4 and T5 was greatly decreased as compared with Ta(F=32.78,P〈0.05). The MAP in T2, Ta, T4 and Ts was declined as compared wl.th that in T1, and that in T3 was lower than that in T2, that in T4 and T5 was higher than that in T3(F=12.51 ,P〈0.05). The HR in Tz, T3 and T4 was greatly increased vs. T1, T4 and T5 were greatly decreased vs. T and T3 (F=21.91 ,P〈0.05). Conclusion PGE1 at 35/Lg · kg^-1 · min^-1 by micro pump shows a better therapeutic effect on pulmonary hypertension in patients undergoing orthotopic liver transplantation.
出处 《青岛大学医学院学报》 CAS 2013年第6期506-508,共3页 Acta Academiae Medicinae Qingdao Universitatis
基金 山东省卫生厅基金项目(2007HW049)
关键词 前列地尔 肝移植 高血压 肺性 alprostadil liver transplantation hypertension, pulmonary
  • 相关文献

参考文献11

  • 1BANDARA M, GORDON F D, SARWAR A, et al. Success- ful outcomes following living donor liver transplanthtion for portopulmonary hypertension[J]. Liver Transpl, 2010,16(8) : 983-989.
  • 2GIUSCA S, JINGA M, JURCUT C, et al. Portopulmonaryhypertension: from diagnosis to treatment[J]. Eur J Intern Med, 2011,22(5) :441-4,47.
  • 3KROWKA M J. Portopulmonary hypertension[J] Semin Re- spir Crit Care Med, 2012,33(1):17-25.
  • 4LU A W, HUANG D S, ZHENG S S, et al. The changes o{ hemodynamics in peri-operative period of orthotopic liver transplantation in patients with chornic hepatic diseases[J]. Journal o[ Zheiiang University Medical Sciences, 2001,30(6) : 245-247.
  • 5TAN H P, MARKOWITZ J S, MONTGOMERY R A, et al. Liver transplantatinn in patients with sevre portnpulmnnary hypertension treated with preoperative chronic intravenous epoprostenol[J]. Liver Transpl, 2001,7 745-749.
  • 6KEEGAN M T, KAMATH G S, VASDFV G M, et al. laver transplantation for masive hepatic haemangiomatosis causing restrictive lung disease[J]. Br J Anaesth, 2001,86:431 434.
  • 7DOMINIK G H, ROBERT A B, AURA G G, et al. PGE1analog alprostadil induces VEGF and eNOS experssion in en dothelialcells[J]. Am J Physiol Heart Cire Physiol, 2005,289 (5) : H2066-H2072.
  • 8GENSCH C, CLEVER Y, WERNER C, et al. Regulation of endothelial progenitor cells by prostaglandin E1 via inhibition of apoptosis[J]. J Mol Cell Cardiol, 2007,42(3) : 670 667.
  • 9HERRLER T, LEICHT S F, HUBER S, et al. Prostaglandin E positively inodulates endothelial progenitor cell honeostasis: an advanced treatment modality for autologous cell therapy [J]. J Vasc Res, 2009,46(4):333-346.
  • 10章政,王成军,刘志明,王新华,毛拥军.PGE_1脂微球对肺心病并心力衰竭病人脑钠肽影响[J].青岛大学医学院学报,2010,46(1):58-59. 被引量:6

二级参考文献18

  • 1章政,邢昂,刘风林.Lipo PGE_1治疗血流减慢型椎基底动脉供血不足在经颅彩色多普勒超声下快速疗效观察[J].中日友好医院学报,2005,19(2):116-117. 被引量:1
  • 2郭振辉,叶曜芩,景炳文,罗文侗,宋志芳,邹霞英.前列腺素E_1联合氧疗对肺动脉高压的作用[J].中华内科杂志,1995,34(1):50-51. 被引量:32
  • 3STRANGE J W, HARTON J, PHILLIPS P G, et al. Recent insights into the pathogenesis and therapeutics of pulmonary hypertension[J]. Clin Sci, 2002,102 : 253-268.
  • 4MORRISON L K, HARRISON A, KRISHNASWAMY P, et al. Utility of a rapid Brain natriuretie peptide assay in derentiating congestive heart failure from lung disease in patients presenting with dyspnea[J]. Am Coll Cardiol, 2002,39 : 202- 209.
  • 5Shen JY, Chen SL , Wu YX, et al. Pulmonary hypertension in systemic lupus erythematosus [J]. Rheumatol Int, 1999,18:147.
  • 6Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxia and cor pulmonale complicating chronic bronchitis and emphysema [J]. Lancet,1981,1:681.
  • 7Naeije R, Melot C, Mols P, et al. Reduction in pulmonary hypertension by prostaglandin E1 in decompensated chronic obstructive pulmonary disease [J]. Am Rev Respir Dis, 1982,125:1.
  • 8Szczeklick J. Effects of Prostaglandin E1 on pulmonary circulation in patients with pulmonary hypertrnsion [J]. Br Heart J,1987, 40: 1397.
  • 9Winslow TM, Ossipov MA, Fazio GP, et al. Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus [J]. Am Heart J, 1995, 129: 510.
  • 10Heerdt PM, Weiss CI. Prostaglandin E1 and intrapulmonary shunt in cardiac surgical patients with pulmonary hypertension[J]. Ann Thorac Surg, 1990, 49: 463.

共引文献8

同被引文献22

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部